In 2015, Horizon Blue Cross Blue Shield of New Jersey launched the controversial OMNIA plan, forcing many consumers to either switch providers or pay more to be treated by their trusted doctors and hospitals. Since that time, Horizon has come under fire by elected officials, legislators and health care experts alike. And a lawsuit brought by a coalition of community hospitals means Horizon will have to defend its ill-conceived plan in court this spring.
Now, Horizon is introducing a new Medicare Advantage plan that would employ a similar restrictive network of hospitals and physicians, based on the flawed OMNIA scheme. New Jersey’s state senators are calling foul and asking Horizon executives to testify and provide answers.
Horizon’s OMNIA scheme dangerously undermines health care delivery in New Jersey by steering patients to large chain hospitals and making it more difficult to get treatment at some of the state's best hospitals — including Holy Name Medical Center, the only CMS 5-star hospital in Northeast New Jersey.
And now with its flawed Medicare Advantage plan, Horizon’s continued manipulation of the healthcare market will have serious consequences for New Jersey hospitals, physicians, and consumers.
A surprise Friday morning announcement from Senate President Stephen Sweeney calls for what would be the second joint Senate committee hearing to scrutinize Horizon Blue Cross Blue Shield of New Jersey’s OMNIA plan since its rollout two years ago.
“More than two years have passed since the Senate Health and Commerce committees held a joint hearing to examine the potential impact of the Horizon OMNIA insurance product. Horizon executives made numerous representations to the joint committee during the hearing,” Sweeney (D-West Deptford) said in a statement.
The leader of the New Jersey Senate says lawmakers will hold a hearing to examine insurance products being offering by Horizon Blue Cross Blue Shield of New Jersey.
Senate President Steve Sweeney says he wants to make sure insurance companies aren’t making enormous profits at the expense of quality health care for consumers.